Urogen Pharma Ltd

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$35.50

+0.35 (+1.00%)

As of Jun 24, 2:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +27.8% upside

Low Target $37.53

Average Target $45.36

High Target $61.85

Current Price $35.50

Current
$35.50

Target
$45.36

$37.53 $45.36 avg $61.85

Scenario Analysis

Bear Case

$37.53

5.7%

Low target

Base Case

$45.36

+27.8%

Avg target

Bull Case

$61.85

+74.2%

High target

Risk/Reward

13.0x

Highly favorable

Price in Context

52-Week High

$33.79

5.1% from high

52-Week Low

$12.73

+178.9% from low

Target vs 52W High

$45.36

+34.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.6%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.9%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+188.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-8.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.9%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.4%